The "fat jab," also known as Saxenda or liraglutide, is an injectable weight-loss drug that has been approved for use on the NHS in the UK for individuals struggling with obesity. It is intended for use in conjunction with a reduced-calorie diet and increased physical activity. The medication helps control appetite, leading to weight loss. It is typically prescribed to those with a BMI over 30 or individuals with weight-related health problems.

The NHS in the UK has started prescribing Wegovy to patients who struggle with obesity and have failed to achieve significant weight loss through diet and exercise. This medication is part of a broader initiative to provide patients with additional tools to combat the obesity epidemic. Wegovy is typically prescribed alongside lifestyle changes to maximize its effectiveness.

The stomach sleeve diet follows the same principles as the gastric sleeve diet. After the surgery, patients must follow a structured eating plan, starting with liquids and progressing to solid foods over several weeks. The diet focuses on small, high-protein meals to support weight loss and ensure adequate nutrition.

Weight loss before surgery was associated with readmission for abdominal pain and increases in urinary tract and surgical site infections, researchers found. The tradition may also be tied to insurance carriers who require weight loss and counseling before surgical treatment.

Turkey offers one of the most affordable options for gastric sleeve surgery worldwide. Despite the lower costs, the quality of care remains high. Many clinics offer competitive packages that include everything from pre-surgical tests to follow-up consultations. The affordability does not equate to compromised quality; rather, it is driven by the lower cost of living and the government’s focus on medical tourism. Patients can receive world-class treatment at a fraction of the cost compared to Western countries.